Clinical Trials
183 trialsA Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults
Qilu Pharmaceutical Co., Ltd.
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer
Tachyon Therapeutics, Inc.
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Kalbe International Pte. Ltd
ELITE
Helio Genomics
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Aadi Bioscience, Inc.
A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
MUST MINI PMS
Medacta International SA
The FuSion Program: A Prospective and Multicenter Cohort Study of Pan-Cancer Screening in Chinese Population
Singlera Genomics Inc.
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours
Catalysis SL
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
R-Pharm
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
AO GENERIUM
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
Activ Surgical
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
A Study of TY-1091 in Patients With Advanced Solid Tumors
TYK Medicines, Inc
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Qilu Pharmaceutical Co., Ltd.
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
HOUSE
Entia Ltd
URODETECT-WP1
Novosanis NV
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Tianjin Chasesun Pharmaceutical Co., LTD
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Monyan Pharmaceutical (Shanghai) Co., Ltd.
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients
Danone Specialized Nutrition
CCGA
GRAIL, Inc.
Phase 1 First-in-human Study of JS014
Anwita Biosciences
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
QureBio Ltd.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Shanghai EpimAb Biotherapeutics Co., Ltd.
Clinical Trial of Autologous Tcm Immunotherapy in ICC
Newish Technology (Beijing) Co., Ltd.
PICC
Shandong Branden Med.Device Co.,Ltd
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
Known Medicine, Inc.
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Immorna Biotherapeutics, Inc.
URODETECT-WP3
Novosanis NV
OPTIMUM
Jubilant DraxImage Inc.
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Celularity Incorporated
XCELSIOR
xCures
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients
Angiodynamics, Inc.
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
LaSanta S A S
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens
Blau Farmaceutica S.A.
MyProstateScore Equivalency With and Without DRE
LynxDx
myCare-102
Cellworks Group Inc.
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors
Sorrento Therapeutics, Inc.
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd